Genprex, Inc.
GNPX
$2.83
$0.093.29%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -45.01% | -48.61% | -23.39% | -20.81% | -20.71% |
| Depreciation & Amortization | -94.85% | -85.12% | -69.85% | -54.36% | -44.89% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.39% | -34.11% | -31.10% | -31.82% | -27.98% |
| Operating Income | 28.39% | 34.11% | 31.10% | 31.82% | 27.98% |
| Income Before Tax | 24.94% | 32.82% | 29.84% | 30.69% | 27.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.94% | 32.82% | 29.84% | 30.69% | 27.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.94% | 32.82% | 29.84% | 30.69% | 27.80% |
| EBIT | 28.39% | 34.11% | 31.10% | 31.82% | 27.98% |
| EBITDA | 28.38% | 34.09% | 31.09% | 31.81% | 27.97% |
| EPS Basic | 91.25% | 86.49% | 74.03% | 62.39% | 50.42% |
| Normalized Basic EPS | 91.39% | 86.55% | 73.96% | 63.27% | 51.12% |
| EPS Diluted | 91.25% | 86.49% | 74.03% | 62.39% | 50.42% |
| Normalized Diluted EPS | 91.39% | 86.55% | 73.96% | 63.27% | 51.12% |
| Average Basic Shares Outstanding | 922.42% | 721.01% | 406.92% | 192.96% | 69.21% |
| Average Diluted Shares Outstanding | 922.42% | 721.01% | 406.92% | 192.96% | 69.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |